Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Avasopasem manganese treatment for severe oral mucositis from chemoradiotherapy for locally advanced head and neck cancer: phase 3 randomized controlled trial (ROMAN).
Journal: EClinicalMedicine
Published: December 29, 2024
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial.
Journal: Nature medicine
Published: August 04, 2024
Benefit of Avasopasem Manganese on Severe Oral Mucositis in Head and Neck Cancer in the ROMAN Trial: Unplanned Secondary Analysis.
Journal: Advances in radiation oncology
Published: March 28, 2024
Stereotactic body radiotherapy plus rucosopasem in locally advanced or borderline resectable pancreatic cancer: GRECO-2 phase II study design.
Journal: Future oncology (London, England)
Published: January 24, 2024
Indoximod-based chemo-immunotherapy for pediatric brain tumors: A first-in-children phase I trial.
Journal: Neuro-oncology
Published: September 16, 2023
Treatment Response in First-Line Metastatic Pancreatic Ductal Adenocarcinoma Is Stratified By a Composite Index of Tumor Proliferation and CD8 T-Cell Infiltration.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 20, 2023
Phase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma.
Journal: Journal for immunotherapy of cancer
Published: March 16, 2021
A Phase 3 Randomized Clinical Trial of Chemotherapy With or Without Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy in Subjects With Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer.
Journal: Annals of surgery
Published: February 25, 2021
Inhibition of the BTK-IDO-mTOR axis promotes differentiation of monocyte-lineage dendritic cells and enhances anti-tumor T cell immunity.
Journal: Immunity
Published: September 08, 2020
Last Updated: 09/26/2026